Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Pulmodual MDI - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Pulmodual MDI

Approved

STANDARD

Pulmodual MDI

Midas-Care Pharmaceuticals Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 8dc4c06cec5d39aa
Company: Midas-Care Pharmaceuticals Pvt. Ltd.
Type: Standard

Approval Details

Approval Id: 8dc4c06cec5d39aa
Drug Approval Philippines Name: Pulmodual MDI
Product Name: Pulmodual MDI
Registration Number: DRP-4809
Brand Name: Pulmodual MDI
Generic Name: Salbutamol (As Sulfate) + Ipratropium Bromide
Dosage Form: Metered Dose Inhaler
Dosage Strength: 100mcg/20mcg Per Actuation
Manufacturer: Midas-Care Pharmaceuticals Pvt. Ltd.
Importer: MedEthix, Inc.
Distributor: The Cathay Drug Co., Inc.
Issuance Date: 28 June 2022
Expiry Date: 28 June 2027
Pharmacologic Category: Bronchodilator
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

8dc4c06cec5d39aa

Type

Standard

Back to Philippines FDA Approvals